Advertisement

Topics

STAT Plus: Novartis and Bayer threaten to sue U.K. agency over a switch to a cheaper drug

10:59 EDT 1 Nov 2017 | STAT

At issue is the Avastin cancer drug, which is widely prescribed by physicians to treat age-related wet macular degeneration, but not approved for that use.

Original Article: STAT Plus: Novartis and Bayer threaten to sue U.K. agency over a switch to a cheaper drug

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Novartis and Bayer threaten to sue U.K. agency over a switch to a cheaper drug"

Quick Search
Advertisement
 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...